Use of Non Biologic DMARD in Rheumatoid Arthritis with Emphasis on Leflunomide

Journal Title: Journal of Medical Science And clinical Research - Year 2017, Vol 5, Issue 7

Abstract

Background: Being the commonest rheumatoligical disease the treatment of rheumatoid arthritis requires optimisation. The use of disease modifying medications in rheumatoid arthritis needs particular emphasis. Many patients presents late with deformities resulting in significant morbidity. Methods: We conducted a prospective study involving 60 patients with active rheumatoid arthritis and a double blind comparison sub study in which outcome of treatment of 35 patients were analysed between methotrexate and leflunomide. Results: The 60 patients studied were predominantly women (mean age, 52 years; mean disease duration, 4.5 years) The ACR response for patients receiving leflunomide treatment was 52% and that of methotrexate treatment was 48%. They were statistically equivalent, with mean time to initial response at 8.2 weeks for patients receiving leflunomide vs 9.1 weeks for patients receiving methotrexate therapy. X-ray analyses demonstrated less disease progression with both arms of the study. Common adverse events for patients receiving leflunomide treatment included gastrointestinal complaints, skin rash, and reversible alopecia. Conclusions: Current treatments for rheumatoid arthritis (RA) include nonsteroidal anti-inflammatory drugs (NSAIDs), low-dose steroids, and disease-modifying antirheumatic drugs (DMARDs). No currently available medication is uniformly effective, and all may cause significant adverse effects. The active control drug for this study, methotrexate, is considered to be the "gold standard" DMARD for the treatment of RA. Clinical responses following administration of leflunomide, a relatively new therapeutic agent for the treatment of RA, were statistically equivalent to those with methotrexate treatment. Both treatments improved signs and symptoms of active RA, delayed disease progression as demonstrated by x-ray films, and improved function and health-related quality of life.

Authors and Affiliations

Ajith S. N

Keywords

Related Articles

A Study on Soft Tissue Sarcomas (STS)

Introduction: STS constitute a significant challenge to the surgeon. They are rare tumor accounting for 1% of all malignancies. There are more than 20 histologic varieties. They are Aggressive neoplasms and have the prop...

Maternal and Fetal Outcome in Cases of Oligohydramnios Diagnosed By Ultrasonography after 34 Weeks of Gestation

The present study “obstetric outcome in cases of oligohydramnios diagnosed after 34 weeks of gestation” is a prospective study and Silchar Medical College & Hospital, Silchar during the period 1st August 2012 to 31st Jul...

Ponseti’s Method: Is It Effective in Conservative Management of Neglected Congenital Talipes Equino Varus

Background: Clubfoot should be ideally corrected in infancy. Developing nations have inadequate medical and surgical resources. The cost of managing clubfoot surgically and the associated crippling deformities in later l...

Aortic root abscess with complete heart block in a patient with acute lymphoblastic leukaemia

Infective endocarditis involving left side of the heart is more common than the right side. Aortic valve involvement is relatively less common than the mitral valve and is usually seen in the setting of underlying pathol...

Vitamin D Status, Insulin Resistance and Arterial Stiffness in Normal Healthy Subjects

Vitamin D deficiency is common worldwide. Presence of vitamin D receptors on various tissues, explains its diversity of actions. Reduced levels of vitamin D is associated with insulin resistance (IR), diabetes, arterial...

Download PDF file
  • EP ID EP527266
  • DOI -
  • Views 81
  • Downloads 0

How To Cite

Ajith S. N (2017). Use of Non Biologic DMARD in Rheumatoid Arthritis with Emphasis on Leflunomide. Journal of Medical Science And clinical Research, 5(7), 25330-25341. https://europub.co.uk/articles/-A-527266